Project Grant K01MH139990
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant totaling $771,272 to New York University School of Medicine, with an award date of March 15, 2026, and ultimate completion date of December 31, 2030, under the Mental Health Research Grants program (CFDA 93.242). This research project investigates prenatal maternal brain plasticity and its associations with maternal and infant neurobehavioral health, with a specific focus on understanding how...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Virginia a Project Grant of $154,880 under the Mental Health Research Grants program (CFDA 93.242) effective September 28, 2025, through September 27, 2028. This research project investigates the mechanisms underlying postpartum depression (PPD) risk by examining the relationship between epigenetic biomarkers at estrogen-responsive genes, negative valence symptoms (fear, anxiety, and sustained...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $467,368 to the Research Foundation For Mental Hygiene, Inc. (operating as the New York State Psychiatric Institute) on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242). This exploratory/developmental R21 project grant, extending through March 31, 2028, supports research investigating the relationship between gestational serotonin levels and offspring neurodevelopment. The research...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $394,200 to the Research Foundation For Mental Hygiene, Inc. (RFMH) under the Mental Health Research Grants program (CFDA 93.242) beginning August 1, 2025, with a completion date of July 31, 2030. This project grant funds a five-year clinical research investigation examining the role of the anterior hippocampus in the pathogenesis of major depressive disorder (MDD). The research leverages functional magnetic...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $844,917 under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through April 30, 2030. The project, titled "Moderate Effect Size Genes in Autism Spectrum Disorder," delivers research services focused on identifying and characterizing moderate effect size (MES) risk genes that contribute to autism spectrum...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant of $200,376.00 under the Mental Health Research Grants program (CFDA 93.242) to The Regents of the University of California, San Francisco for research activities spanning April 1, 2026, through March 31, 2031. The grant funds a longitudinal research investigation examining the mechanisms through which prenatal maternal inflammation (PMI) and parenting behaviors influence child mental health...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Massachusetts Medical School a Project Grant of $159,743 under the Mental Health Research Grants program (CFDA 93.242) on September 15, 2025, with a completion date of August 31, 2029. This award supports the development and evaluation of "REACHING CALM," a digital intervention designed to prevent perinatal anxiety disorders. The research addresses a significant public health need, as...
- Federal Grant Award Summary The Feinstein Institutes for Medical Research received a $1,659,568 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 2, 2025, with completion targeted for May 31, 2030. The award funds the ESPRITO EPINET project, which aims to expand a learning health system (LHS) framework for improving treatment outcomes in early first-episode psychosis (FEP) care. The project will enroll an...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai has been awarded $813,406 under the Mental Health Research Grants program (CFDA 93.242) administered by the National Institute of Mental Health to conduct a five-year research project from July 1, 2025, through March 31, 2030. The research project investigates the role of oxytocin in modulating activity of the supramammillary nucleus (SUM) and its impact on social recognition memory. The grant funds scientific research...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Feinstein Institutes for Medical Research a Project Grant of $519,558 under the Mental Health Research Grants program (CFDA 93.242), effective June 15, 2025 through April 30, 2030. The research project focuses on identifying and validating cerebellar-cortical circuitry biomarkers as predictive indicators of antipsychotic treatment response in first-episode psychosis patients. The primary deliverables...
The National Institute of Mental Health (NIMH) awarded $717,688 to Icahn School of Medicine at Mount Sinai under the Mental Health Research Grants program (CFDA 93.242) on May 1, 2026, for a four-year project period concluding April 30, 2030. This K01 Career Development Award supports a research investigation into the molecular and epigenetic mechanisms by which postpartum stress interacts with parity to influence vulnerability to perinatal and postpartum mood and anxiety disorders (PMADs). The research employs a novel parity by postpartum stress mouse model to identify transcriptomic and epigenetic dysregulation in the dorsal hippocampus and dopaminergic pathways from the ventral tegmental area that underlie anxiety-like phenotypes and loss of cognitive adaptations following postpartum stress exposure. Under the mentorship of Dr. Ian Maze, the investigator will conduct three specific aims designed to elucidate how epigenetic regulation of ventral tegmental area-dorsal hippocampus projections mediates the interaction between parity and postpartum stress. The deliverables include characterization of transcriptomic sensitivity and epigenetic changes in response to maternal experience and stress, mechanistic understanding of dopamine dysregulation, and identification of therapeutic targets for intervention in at-risk postpartum populations. This research addresses a critical gap in understanding factors influencing PMAD risk and contributes to NIMH's mission to transform understanding and treatment of mental illnesses through basic and clinical research.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $717.7k | 3/19/26 |